Content
08/27/2024
Scotch Plains, NJ USA
Navigator Medicines
completed $100 million Series A Round funding. Investors include
RA Capital Management (lead), Forbion Capital Partners (lead).
About
Navigator Medicines is a biotech company leading the advancement of biologics for targeted immune regulation & restoration. Founded in 2024 as a subsidiary of Sera Medicines, the Company is committed to developing new therapies for patients living with complex, heterogeneous autoimmune diseases.
Startup
Navigator Medicines
https://www.navigatormedicines.com
Claim Profile
Location:
Scotch Plains, NJ USA
Sector:
Biotech
Life Science
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
